132 related articles for article (PubMed ID: 29158505)
1. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study.
Yan HX; Pang P; Wang FL; Tian W; Luo YK; Huang W; Yang GQ; Jin N; Zang L; Du J; Ba JM; Dou JT; Mu YM; Lyu ZH
Sci Rep; 2017 Nov; 7(1):15832. PubMed ID: 29158505
[TBL] [Abstract][Full Text] [Related]
2. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
3. [Association between the serum TSH concentration and thyroid cancer incidence].
Li JZ; Jin YJ; Liu X; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):921-4. PubMed ID: 22340102
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.
Shi L; Li Y; Guan H; Li C; Shi L; Shan Z; Teng W
Endocr J; 2012; 59(11):973-80. PubMed ID: 22785429
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of thyroid cancer in China.
Yang Y; Li Q; Guo L; Cui M; Bao T; Zhang Z; Wang C; Ni Y; Zhang J
Asian Pac J Cancer Prev; 2011; 12(9):2245-9. PubMed ID: 22296364
[TBL] [Abstract][Full Text] [Related]
6. Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?
Swan KZ; Nielsen VE; Godballe C; Thrane JF; Mortensen MR; Schytte S; Pedersen HB; Christiansen P; Bonnema SJ
Endocrine; 2018 Aug; 61(2):308-316. PubMed ID: 29855783
[TBL] [Abstract][Full Text] [Related]
7. The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis.
Su A; Zhao W; Wu W; Wei T; Ruan M; Li Z; Zhu J
Am J Surg; 2020 Sep; 220(3):634-641. PubMed ID: 31955813
[TBL] [Abstract][Full Text] [Related]
8. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
[TBL] [Abstract][Full Text] [Related]
11. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
[TBL] [Abstract][Full Text] [Related]
12. An elevated level of TSH might be predictive of differentiated thyroid cancer.
Dorange A; Triau S; Mucci-Hennekinne S; Bizon A; Laboureau-Soares S; Illouz F; Rodien P; Rohmer V
Ann Endocrinol (Paris); 2011 Dec; 72(6):513-21. PubMed ID: 22115282
[TBL] [Abstract][Full Text] [Related]
13. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.
Pellegriti G; Mannarino C; Russo M; Terranova R; Marturano I; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 2013 Mar; 98(3):1014-21. PubMed ID: 23348395
[TBL] [Abstract][Full Text] [Related]
14. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
15. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
[TBL] [Abstract][Full Text] [Related]
16. [Gender-related clinical characteristics in patients with differentiated thyroid cancers].
Yan H; Gu W; Lyu Z; Yang G; Ba J; Wang X; Ouyang J; Guo Q; Du J; Jin N; Zang L; Dou J; Mu Y
Zhonghua Nei Ke Za Zhi; 2014 Apr; 53(4):286-9. PubMed ID: 24857302
[TBL] [Abstract][Full Text] [Related]
17. Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules.
Giovanella L; Maffioli M; Suriano S; Dorizzi RM
Clin Endocrinol (Oxf); 2010 Jun; 72(6):852-3. PubMed ID: 19863575
[No Abstract] [Full Text] [Related]
18. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
Park S; Kim WG; Han M; Jeon MJ; Kwon H; Kim M; Sung TY; Kim TY; Kim WB; Hong SJ; Shong YK
Thyroid; 2017 Sep; 27(9):1164-1170. PubMed ID: 28699428
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
